Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153
PaperCitations, authors & open-access status
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 241 citations, 2020 year and hybrid oa status.
241
Citations
2020
Year
hybrid
OA Status